Olav Dahl

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 530 citations

Medicine, Oncology, Pharmacology +16

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

Hege Sagstuen Haugnes, Torgeir Wethal, Nina Aass et al. · Journal of Clinical Oncology · 2010 · 400 citations

Medicine, Oncology, Radiation Oncology +14

Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer

Kjersti Bruheim, Marianne G. Guren, Eva Skovlund et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 285 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Paternity Following Treatment for Testicular Cancer

Marianne Brydøy, Sophie D. Fosså, Olbjørn Klepp et al. · JNCI Journal of the National Cancer Institute · 2005 · 268 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Torgrim Tandstad, Olav Dahl, Gabriella Cohn‐Cedermark et al. · Journal of Clinical Oncology · 2009 · 266 citations · Full text

Medicine, Oncology, Cancer Control +15